FindTrial
Sign In

Clinical application of contrast-enhanced ultrasound (SonoVue) in the diagnosis and treatment of thyroid cancer after surgery

Clinical application of contrast-enhanced ultrasound (SonoVue) in the diagnosis and treatment of thyroid cancer after surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056138
Enrollment
Unknown
Registered
2022-02-01
Start date
2022-02-01
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid cancer

Interventions

Lymph node metastasis group:None
Non-lymph node metastasis group:None

Sponsors

The Second Hospital of Shandong University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients with pathologically confirmed DTC after total thyroidectomy or subtotal thyroidectomy; 2. 131I treatment is required after surgery;

Exclusion criteria

Exclusion criteria: 1. Patients with other malignant tumors; 2. Patients with incomplete clinical data or lost to follow-up.

Design outcomes

Primary

MeasureTime frame
ultrasonographic characteristics;response to treatment;—

Secondary

MeasureTime frame
131I whole body scan;Thyroglobulin;—

Countries

China

Contacts

Public ContactZhang Wei

The Second Hospital of Shandong University

sdeyzhangwei@163.com+86 17660086070

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026